Summary:
Miami Dade Medical Research Institute is conducting a randomized double blind placebo-controlled study to evaluate the safety and efficacy of elagolix in subjects with moderate to severe endometriosis associated pain.
Qualified Participants Must:
• Be a Pre-Menopausal Female
•
Be between 18 and 49 years of age
•
Have a clinical diagnosis of Endometriosis
•
Have a documented surgical visualization (laparoscopy or laparotomy performed within
10 YEARS of entry into the
Washout Period (if applicable)
or screening period.
Qualified Participants May Receive:
$2,190 for time
and transportation
.